Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Forkhead box protein C2 (FOXC2) is a DNA-binding transcription factor belonging to the forkhead box (FOX) family and is encoded by the *FOXC2* gene, which is intronless and encodes a 501-amino-acid protein[4][2]. FOXC2 regulates crucial developmental processes, including vascular and lymphatic development, kidney and heart formation, and differentiation of adipose tissue, as well as maintenance of glomerular basement membrane integrity[4]. It plays a pivotal role in the epithelial-mesenchymal transition (EMT), which is linked to cancer metastasis, and its mutations are causatively associated with lymphedema–distichiasis syndrome (a genetic disorder of the lymphatic system)[4][2]. FOXC2 exerts its function by directly binding to specific DNA motifs, regulating gene transcription; it is essential for the formation of pericyte-free lymphatic networks and lymphatic valves[3][1][2]. Overexpression is associated with highly metastatic cancers, especially breast cancer, and the gene is both a disease biomarker and a potential therapeutic target in cancer and lymphatic disorders[4][1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Forkhead box protein C2 (FOXC2).